Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate

Conditions

• Bladder Small Cell Neuroendocrine Carcinoma
• Castration-Resistant Prostate Carcinoma
• Metastatic Bladder Urothelial Carcinoma
• Metastatic Urethral Urothelial Carcinoma
• Prostate Carcinoma Metastatic in the Bone
• Prostate Neuroendocrine Neoplasm
• Prostate Small Cell Carcinoma
• Stage III Bladder Cancer American Joint Committee on Cancer ( AJCC) v8
• Stage III Prostate Cancer AJCC v8
• Stage III Urethral Cancer AJCC v8
• Stage IV Bladder Cancer AJCC v8
• Stage IV Prostate Cancer AJCC v8
• Stage IV Urethral Cancer AJCC v8
• Stage IVA Bladder Cancer AJCC v8
• Stage IVB Bladder Cancer AJCC v8
• Ureter Small Cell Carcinoma
• Urothelial Carcinoma

Interventions

• DRUG: Carboplatin
• DRUG: Cisplatin
• DRUG: Docetaxel
• DRUG: Etoposide
• BIOLOGICAL: Pembrolizumab

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

• [object Object]